Italian Scientists Protest Evaluations

A scheme introduced by the Italian government to evaluate the country’s researchers and universities has come under fire from critics who say the criteria are too crude.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, PIETRO RICCIARDIThe Italian government is attempting to safeguard the quality of the nation’s science by evaluating researchers and institutions, and by rewarding those that meet certain criteria with opportunities for promotion and increased funding. But the move has angered many Italian scientists, who argue that the evaluations rely on flawed metrics that don’t accurately reflect research quality, and will therefore not reward the best scientists.

In an effort to root out nepotism in academia, the National Agency for the Evaluation of Universities and Research Institutes (ANVUR) implemented the new review scheme in 2011. Evaluators use three criteria: the number of papers published in the last 10 years, the number of citations accrued, and the “h-index” of those publications—a measure of both output and impact. Only applications that score above the national median on 2 of the 3 criteria can get the stamp of approval required to apply for higher positions. And only the top-ranking universities can expect to receive extra funding.

But many scientists argue that the criteria are too crude to identify the true leaders. Some groups—including the Mathematics Union and the Association of Psychologists—have launched official protests. “It's ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies